PIS
CLPT icon

POM Investment Strategies’s ClearPoint Neuro CLPT Stock Holding History

POM Investment Strategies’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15
Closed -$231 – 242
2024
Q4 		$231 Hold
15
– – ﹤0.01% 332
2024
Q3 		$168 Hold
15
– – ﹤0.01% 303
2024
Q2 		$81 Hold
15
– – ﹤0.01% 320
2024
Q1 		$102 Hold
15
– – ﹤0.01% 248
2023
Q4 		$102 Buy
+15
New +$85 ﹤0.01% 229

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

POM Investment Strategies's CLPT Position: Q1 2025 in Review

POM Investment Strategies sold out of ClearPoint Neuro (CLPT) in Q1 2025, closing a stake of 15 shares — an estimated $231 sold.

POM Investment Strategies first reported a position in CLPT in Q4 2023 and held it in 5 quarters. The position peaked at $231 in Q4 2024. 101 funds tracked by Wall St. Rank hold CLPT as of Q1 2025.

  • POM Investment Strategies reported no remaining ClearPoint Neuro position as of Q1 2025 after selling out during the quarter.
  • POM Investment Strategies sold 15 ClearPoint Neuro shares in Q1 2025, an estimated $231.
  • POM Investment Strategies first reported a position in ClearPoint Neuro in Q4 2023 and held it in 5 quarters.
  • POM Investment Strategies's ClearPoint Neuro position peaked at $231 in Q4 2024.
  • 101 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2025.

Based on POM Investment Strategies's 13F filing for Q1 2025, filed 30 Apr 2025.